Search
Vera Therapeutics Inc
VERAAdd to Watchlist
29.785USD
-0.355-1.18%
Close 11-06 16:00（ET）
2.15BMarket Cap
LossP/E TTM
Today
-1.18%
5 Days
-3.86%
1 Month
+0.18%
6 Months
-17.70%
Year to Date
-41.18%
1 Year
+23.13%
Key Figures
30.480Open
30.840High
224.74KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.31%Turnover Ratio
30.140Prev. Close
28.037Low
6.67MTurnover
LossP/E Static
5.26P/B
0.00%Div Yield TTM
-59.90%ROA
56.05052wk High
0.14Volume Ratio
-152.15MNet Profit
72.06MShares
-5.5459EPS TTM
0.93Beta
-71.32%ROE
23.86052wk Low
13.50%Amplitude
67.93%Gross Margin
2.15BMarket Cap
-4.03Reward/Risk
3.86%Risk Rate
Analyst Rating
Vera Therapeutics Inc Technical Analysis
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Strong sell
Vera Therapeutics Inc Latest Earnings Call Transcripts
Vera Therapeutics (VERA) Q3 2026 Earnings Call: TRUTAKNA Launch and ORIGIN 3 Results
Vera Therapeutics Q3 2026 earnings call: TRUTAKNA generated $10.3 million in revenue, reached about 700 patient start forms, and advanced toward full FDA approval.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
-1.30/-1.61
Revenue / Forecast
10.28M/3.96M
Vera Therapeutics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolVERA
Number of employees112
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Avoro Capital Advisors LLC | 8.20% |
| Longitude Capital Management Co., LLC | 7.51% |
| T. Rowe Price Associates, Inc. | 7.51% |
| BlackRock Institutional Trust Company, N.A. | 5.89% |
| Shareholder Types | Proportion |
|---|---|
| Hedge Fund | 38.17% |
| Investment Advisor | 35.87% |
| Investment Advisor/Hedge Fund | 24.31% |
| Venture Capital | 11.76% |
Related Instruments
-0.79%
+1.43%
+1.07%
-0.14%
+0.38%
-0.22%
+0.03%
-0.41%
+0.02%
-0.20%
+0.85%
-1.57%
-1.04%
+0.28%
+5.27%
-0.16%
+0.16%
-0.80%
+1.46%
+3.63%Popular Instruments
51932.500
+641.900 (+1.25%)
27218.100
+253.600 (+0.94%)
7442.700
+62.700 (+0.85%)
12797.000
-1.000 (-0.01%)
59273.000
+1131.000 (+1.95%)
6270.200
+129.600 (+2.11%)
86.082
-3.775 (-4.20%)
342.370
-1.800 (-0.52%)
186.640
+5.040 (+2.78%)
4123.420
+57.750 (+1.42%)
FAQs
What is the current price of Vera Therapeutics Inc (VERA)?
The current price of Vera Therapeutics Inc (VERA) is 29.79.
What is the symbol of Vera Therapeutics Inc?
The ticker symbol of Vera Therapeutics Inc is VERA.
What is the 52-week high of Vera Therapeutics Inc?
The 52-week high of Vera Therapeutics Inc is 56.05.
What is the 52-week low of Vera Therapeutics Inc?
The 52-week low of Vera Therapeutics Inc is 23.86.
What is the market capitalization of Vera Therapeutics Inc?
The market capitalization of Vera Therapeutics Inc is 2.15B.
Is Vera Therapeutics Inc (VERA) currently rated as Buy, Hold, or Sell?
According to analysts, Vera Therapeutics Inc (VERA) has an overall rating of Buy, with a price target of 73.08.
What is the Earnings Per Share (EPS TTM) of Vera Therapeutics Inc (VERA)?
The Earnings Per Share (EPS TTM) of Vera Therapeutics Inc (VERA) is -5.55.